BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7543872)

  • 1. Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain.
    Flynn JN; Cannon CA; Reid G; Rigby MA; Neil JC; Jarrett O
    Immunology; 1995 Jun; 85(2):171-5. PubMed ID: 7543872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
    Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
    Dean GA; LaVoy A; Burkhard MJ
    Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein.
    Freer G; Giannecchini S; Tissot A; Bachmann MF; Rovero P; Serres PF; Bendinelli M
    Virology; 2004 May; 322(2):360-9. PubMed ID: 15110533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
    Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
    Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.
    Flynn JN; Cannon CA; Neil JC; Jarrett O
    J Virol; 1997 Oct; 71(10):7586-92. PubMed ID: 9311839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
    Lombardi S; Garzelli C; Pistello M; Massi C; Matteucci D; Baldinotti F; Cammarota G; da Prato L; Bandecchi P; Tozzini F
    J Virol; 1994 Dec; 68(12):8374-9. PubMed ID: 7966629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein.
    Song W; Collisson EW; Li J; Wolf AM; Elder JH; Grant CK; Brown WC
    Virology; 1995 Jun; 209(2):390-9. PubMed ID: 7778274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.
    Flynn JN; Cannon CA; Beatty JA; Mackett M; Rigby MA; Neil JC; Jarrett C
    J Virol; 1994 Sep; 68(9):5835-44. PubMed ID: 8057464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
    AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunity does not protect from challenge with the feline immunodeficiency virus.
    Reggeti F; Bienzle D
    Vet Immunol Immunopathol; 2008 Jul; 124(1-2):152-62. PubMed ID: 18471896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.
    Omori M; Pu R; Tanabe T; Hou W; Coleman JK; Arai M; Yamamoto JK
    Vaccine; 2004 Dec; 23(3):386-98. PubMed ID: 15530685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
    Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
    J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
    Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
    Pu R; Omori M; Okada S; Rine SL; Lewis BA; Lipton E; Yamamoto JK
    Cell Immunol; 1999 Nov; 198(1):30-43. PubMed ID: 10612649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
    Hohdatsu T; Sasagawa T; Yamazaki A; Motokawa K; Kusuhara H; Kaneshima T; Koyama H
    Arch Virol; 2002 Aug; 147(8):1517-29. PubMed ID: 12181672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope.
    Richardson J; Fossati I; Moraillon A; Castelot S; Sonigo P; Pancino G
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():759-71. PubMed ID: 8627265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.